Scholar Rock Announces New Srk-439 Preclinical Data Showing Significant Lean Mass Preservation and Attenuation of Fat Mass Rebound Following GLP-1 Receptor Agonist Withdrawal
學者巖宣佈新的Srk-439臨床前數據,顯示明顯的瘦體重保留,減緩脂肪量反彈,隨着GLP-1受體激動劑的撤退。
Scholar Rock Announces New Srk-439 Preclinical Data Showing Significant Lean Mass Preservation and Attenuation of Fat Mass Rebound Following GLP-1 Receptor Agonist Withdrawal
學者巖宣佈新的Srk-439臨床前數據,顯示明顯的瘦體重保留,減緩脂肪量反彈,隨着GLP-1受體激動劑的撤退。
譯文內容由第三人軟體翻譯。